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Cigarette smoking and vascular pathology in renal biopsies. ulation [1, 2]. In recent years smoking has been pin-
Background. In recent years cigarette smoking has been pointed as a progression factor for chronic nephropa-
identified as a progression factor in chronic nephropathies such thies. Tobacco abuse is highly associated with clinicallyas glomerulonephritis or diabetic nephropathy. The exact pa-
important reduction in renal function in elderly peoplethomechanism of nicotine-induced renal damage is, however,
[3] and with albuminuria in patients with hypertensionunknown. Autopsy studies and functional investigations sug-
gest that the renal vasculature is primarily affected by smoking. [4]. The Multiple Risk Factor Intervention Trial found
Methods. Renal vascular pathology, that is, glomeruloscle- smoking to be a significant risk factor for end-stage re-
rosis, hyalinosis of arterioles and myointimal hyperplasia of
nal disease (abstract; Whelton et al, J Am Soc Nephrolsmall arteries, was determined in 135 biopsies of patients over
6:408a, 1995). In patients with kidney disease, smokingthirty years of age. A questionnaire about smoking habits was
returned by 107 of the patients. For glomerular sclerosis the is associated with elevated serum creatinine levels in
percentage of sclerotic glomeruli was determined, whereas ar- chronic glomerulonephritis [5] and speeds up loss of glo-
teriolar hyalinosis and myointimal hyperplasia of small arteries merular filtration in lupus nephritis [6] and diabetic ne-were described as present or absent without further quantifica-
phropathy in type I and type II diabetes [7–9]. In patientstion. A univariate analysis was performed for existence of vas-
with autosomal dominant polycystic kidney disease andcular changes and ever-smoking status. In addition, a multivari-
ate analysis for glomerular sclerosis and logistic regression IgA nephropathy nicotine abuse increases the risk of
analysis for arteriolar hyalinosis and myointimal hyperplasia end-stage renal disease [10].
and the variables ever-smoking, age, body mass index, creati-
Despite these clinical data the mechanism by whichnine clearance, blood pressure and lipids were performed.
smoking and nicotine exert their deleterious effects onResults. Creatinine clearance was comparable for nonsmok-
ers, ex-smokers and smokers. Frequency of myointimal hyper- a predamaged kidney are largely unknown. Autopsy
plasia of small arteries was twice as high in ever-smokers as studies in individuals without kidney disease showed a
compared to nonsmokers (50% vs. 25.5%, P 0.01). Arteriolar correlation between nicotine abuse and thickening of
hyalinosis was detected in 23.5% of nonsmokers and in 35.7%
the walls of arterioles and small arteries in various organsof smokers, showing a trend toward hyalinosis in ever-smokers
[11] and the kidneys [12, 13]. At present, it is not known(P  0.20). Glomerular sclerosis was found in 62.7% of non-
smokers and in 69.6% of ever-smokers. Logistic regression whether analogous effects of smoking on renal vessels
analysis confirmed an association between ever-smoking and are operative in patients with chronic nephropathies or
myointimal hyperplasia (P  0.01). This association also was whether they might be the cause of accelerated deterio-
present in males and patients over fifty years of age, but not
ration of renal function in smokers suffering from kidneyin younger patients and females.
disease. To shed some light on this problem we investi-Conclusion. In patients with renal, especially glomerular dis-
ease, cigarette smoking exhibits its deleterious effect on the gated damage of renal vessels, defined as sclerosis of
kidneys primarily through damage of small interlobular arteries. glomerular capillaries, hyalinosis of arterioles and myo-
intimal hyperplasia of interlobular arteries, in kidney
biopsies and correlated these findings with the smoking
Cigarette smoking is an established risk factor for car- habit of the patients.
diovascular disease and malignancies in the general pop-
METHODS
Key words: glomerulonephritis, glomerulosclerosis, arterioles, nico-
Patientstine, renal vasculature, progressive renal disease, hypertension.
All 567 patients undergoing a kidney biopsy at our
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Table 2. Histological diagnosis of renal biopsiesTable 1. Characterization of patients
Variable Diagnosis Number of cases (107)
Focal segmental glomerulosclerosis 18Age 4812 [47 (30-74)]
Body mass index 25.44.3 IgA nephropathy 20
Membranous nephropathy 15Creatinine clearance mL/min 6737 [67 (6-168)]
Proteinuria g/24 h 4.34.4 [2.8 (0.1-26.5)] Rapidly progressive glomerulonephritis 9
Minimal change nephropathy 8Systolic RR mm Hg 15227
Diastolic RR mm Hg 9114 Nephrosclerosis 8
Membranoproliferative glomerulonephritis 6Serum cholesterol mg/dL 24282
HDL cholesterol mg/dL 5121 Mesangial glomerulonephritis 6
Lupus nephritis 5LDL cholesterol mg/dL 15776
Serum triglycerides mg/dL 17787 [171 (49-544)] Chronic interstitial nephritis 3
Acute interstitial nephritis 2Values are presented as mean  SD and as [median (range)] where appro-
Alport syndrome 2priate.
Thin basement membranes 1
Light chain nephropathy 1
Diabetic nephropathy 1
Renal fibrosis 1
Normal kidney 1least three glomeruli and one section of an interlobular
artery as well as arterioles had to be present in the tissue
specimen of each biopsy. These criteria were met in 135
cases. The absence of an interlobular artery was by far
Any glomerulus showing segmental or complete sclerosisthe most frequent exclusion criterion.
was classified as affected by glomerular capillary sclero-
sis. The percentage of affected glomeruli was calculatedAssessment of smoking habits
for each biopsy. The number of arterioles was assessed
We sent each patient a letter explaining the purpose
in each biopsy. Due to the smaller numbers of arterioles,
of the study and a questionnaire about smoking habits.
any biopsy showing hyalinosis in at least one arteriole
The letter included a statement saying that by replying was classified positive for the presence of hyalinosis.
to the questionnaire the patient would not incur any Likewise, the number of interlobular arteries was deter-
disadvantage whatsoever. The return sheet was anony- mined, and any case showing myointimal hyperplasia in
mous and allowed identification of the participant by a at least one vessel was classified as affected. The patholo-
number known only to the investigators. Patients had gist evaluating the biopsies was unaware of the patients’
to state whether they were nonsmokers, ex-smokers or smoking status.
current smokers, the number of cigarettes they smoked
or had smoked per day and the total number of years Statistical analysis
for calculation of pack-years until the date of biopsy. Creatinine clearance and the relative frequency of af-
Patients were also questioned whether they had suffered fected glomeruli between patients with various smoking
a myocardial infarction or stroke. The questionnaire was habits were compared by analysis of variance (AN-
returned by 107 patients (79.3%). This return rate is OVA). The presence of arteriolar hyalinosis and of myo-
identical to the one reported in the study by Orth et al intimal hyperplasia of interlobular arteries in patients of
(82.1%) [10]. These 107 patients comprise the total study various smoking habits was compared using Pearson’s
population. 2 test. Multiple regression analysis was used to identify
variables influencing the percentage of glomeruli withAdditional variables
sclerosis. Logistic regression analysis was applied to ana-
The following further variables were obtained from lyze of variables influencing arteriolar hyalinosis and myo-
all patients: age at time of biopsy, sex, body mass index, intimal hyperplasia. Statistical analysis was performed
systolic and diastolic blood pressure measured at the last with the Statistical Package for the Social Sciences for
visit before biopsy, creatinine clearance calculated with Windows 10.0.7 (SPSS, Inc., Chicago, IL, USA).
the Cockcroft and Gault formula, 24-hour urinary pro-
tein excretion determined either in a 24-hour urine sam-
RESULTSple or calculated as protein/creatinine ratio, serum cho-
Patient characteristicslesterol and triglyceride levels.
The patient group consisted of 67 (62.6%) male and
Evaluation of glomerular sclerosis and vascular 40 (37.4%) female subjects. Their mean age was 48 years
pathology in renal biopsies (range 30 to 74). The variables determined in these pa-
Histological evaluation of biopsies was based on the tients are shown in Table 1. Histological evaluation of
mean (range) of 13.2 (3 to 50) glomeruli, 5.4 (2 to 16) renal biopsies revealed glomerular disease in 92 patients
(86%) nephrosclerosis in eight and interstitial nephritisarterioles and 1.8 (1 to 7) interlobular arteries per biopsy.
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Table 3. Smoking habit of patients
Ex-smokers Smokers
Smokers
N Nonsmokers % % pack-years % pack-years (Tyrolean population 16)a
All patients 107 47.7% 16.8% 27.824.5 35.5% 28.717.9 26.6%
Men 67 43.3% 20.9% 32.325.5 35.8% 36.116.5 32.6%
Women 40 55.0% 10.0% 12.610.9 35.0% 16.612.9 21.4%
a Data obtained from the Austrian Microcensus 1991 [15]
Table 4. Smoking habit of patients, renal function, blood pressure, renal vascular pathology and non-renal vascular disease
Nonsmokers Ex-smokers Smokers Ever-smokers
(N  51) (N  18) (N  38) (N  56)
Cr clearance mL/min 65.437.6 61.838.4 68.636.1 66.436.6
Systolic RR mm Hg 14823 15633 15628 15630a
Diastolic RR mm Hg 9012 9218 9216 9216
With glomerular sclerosis 32 (62.7%) 12 (66.6%) 27 (71.0%) 29 (69.6%)
Affected glomeruli % 22.326 21.429.4 26.325.2 24.726.5
With arteriolar hyalinosis 12 (23.5%) 5 (27.8%) 15 (39%) 20 (35.7%)b
With arterial myointimal hyperplasia 13 (25.5%) 9 (50%) 19 (50%) 28 (50%)c
Myocardial infarctione 1 (2.0%) — 2 (5.6%) 2 (3.7%)
Strokee 2 (3.9%) 2 (11.1%) 4 (11.1%) 6 (11.1%)d
a P  0.14, bP  0.2, c P  0.01, d P  0.17 in comparison with nonsmokers
e Data from two patients are missing
in five. One biopsy revealed normal tissue and one con- ences were observed between nonsmokers and smokers,
tained only scarred tissue. A detailed list of histological ex-smokers or ever-smokers. A subgroup analysis of
diagnoses is given in Table 2. male and female patients and of patients over fifty years
The demographic data of the 28 non-responders were of age also showed no influence of smoking on renal
comparable to those of the patients who had responded function.
to the questionnaire. Out of the 28 non-responders 19
Smoking and blood pressure(67.8%) were male and nine (32.2%) female, their mean
age was 50 years and renal histology revealed an underly- Ever-smokers had somewhat higher systolic blood
ing glomerular disease in 23 (82.1%) of them. pressure compared to nonsmokers, although the differ-
ence was not significant (P  0.14; Table 4). DiastolicSmoking habits
blood pressure was comparable between groups.
Patient smoking habits are depicted in Table 3, where
they are compared to the findings of an Austrian nation- Vascular pathology in renal biopsies
wide questionnaire from 1991, which describes smoking The proportion of patients with partially or totally
habits in the total population older than 16 years [14]. sclerotic glomeruli and the extent of glomerulosclerosis
The percentage of current smokers among total study
was similar among nonsmokers, ex-smokers, smokers
patients was markedly higher than in the general popula-
and ever-smokers (Table 4). Smokers and ever-smokerstion (35.5 vs. 26.6%). This increase was caused by the
showed a trend to be affected more often by renal arteri-high proportion of female smoking patients, which was
olar hyalinosis, but the difference did not reach signifi-much greater as compared to the general population
cance (P  0.20). The proportion of patients with myo-(35 vs. 21.4%). The proportion of male smokers among
intimal hyperplasia of interlobular arteries was twice aspatients and in the Austrian Microcensus 1991 was al-
high in smokers, ex-smokers and ever-smokers as com-most identical (35.8 vs. 32.6%). The percentage of male
pared to the nonsmoking patients. The difference be-patients who had quit smoking was much higher than
tween never-smokers and ever-smokers was statisticallyfemale patients. The number of pack-years was identi-
significant (P  0.01) (Table 4).cal between ex-smokers and current smokers. Women
smoked less than half as many pack-years than did men.
Non-renal vascular disease
Smoking and renal function A tendency toward higher frequency of myocardial
infarction and especially stroke in ever-smokers was ob-Creatinine clearance for the different groups ac-
cording to smoking habit is shown in Table 4. No differ- served (P 0.17 for stroke; Table 4). The absolute num-
Lhotta et al: Smoking and renal vascular pathology 651
Table 6. Logistic regression analysis of variables associatedTable 5. Multiple regression analysis of variables influencing the
percentage of glomeruli with sclerosis with arteriolar hyalinosis
Group and variable Coefficient SEM Pr of total
Group and variable Coefficient SEM P model
All patients (N  107)
Systolic RR 0.024 0.009 0.005All patients (N  107) 0.43
Systolic RR 0.422 0.087 0.001 Smoking 0.44
Male patients (N  67)Smoking 0.76
Male patients (N  67) 0.61 Systolic RR 0.019 0.011 0.08
Smoking 0.60Systolic RR 0.296 0.122 0.0018
Body mass index 2.685 0.799 0.001 Female patients (N  40)
Systolic RR 0.031 0.015 0.036Cr clearance 0.312 0.093 0.001
Age 0.679 0.278 0.0018 Smoking 0.69
Age 50 years (N  62)Smoking 0.38
Female patients (N  40) 0.51 Systolic RR 0.17
Smoking 0.20Diastolic RR 0.875 0.242 0.001
Smoking 0.82 Age 50 years (N  45)
Systolic RR 0.069 0.024 0.004Age 50 years (N  62) 0.55
Cr clearance 0.316 0.089 0.001 Smoking 0.61
Systolic RR 0.239 0.107 0.03 Smoking was defined as never-smoking/ever-smoking.
Smoking 0.69
Age 50 years (N  45) 0.69
Systolic RR 0.504 0.129 0.001
Body mass index 2.504 0.770 0.002
Table 7. Logistic regression analysis of variables associatedSmoking 0.97
with myointimal hyperplasia of small arteries
Only significant variables and smoking are shown. Smoking was defined as
never-smoking/ever-smoking. Group and variable Coefficient SEM P
All patients (N  107)
Smoking 1.263 0.447 0.0047
Cr clearance 0.018 0.006 0.0051
Male patients (N  67)ber of events was small, precluding a reasonable statisti-
Smoking 1.633 0.656 0.13cal analysis.
Cr clearance 0.019 0.009 0.044
Female patients (N  40)
Multiple and logistic regression analyses Smoking — — 0.55
Age 50 years (N  62)Multiple regression analysis of variables influencing the Age 0.194 0.068 0.004
relative proportion of glomeruli with sclerosis showed a BMI 0.224 0.107 0.036
Cr clearance 0.021 0.011 0.044significant correlation with systolic blood pressure for
Smoking 0.66the whole patient group (P  0.001; Table 5). Smoking Age 50 years (N  45)
was not associated with glomerulosclerosis (P  0.76). Smoking 1.727 0.695 0.013
A subgroup analysis of males and females and of patients Smoking was defined as never-smoking/ever-smoking.
under or over fifty years of age also showed no associa-
tion with ever-smoking. In male patients systolic blood
pressure and body mass index showed a positive, clear-
with clearance in the whole patient group as well as inance and age a negative correlation with the relative
male patients (Table 7). In females no correlation wasproportion of sclerotic glomeruli. In females the only
observed. In patients under fifty years of age, age wasassociation found was with diastolic blood pressure. Pa-
positively, and body mass index and clearance were nega-tients under fifty years exhibited a negative correlation
tively associated with myointimal hyperplasia. In pa-with clearance and a positive one with systolic blood
tients over fifty years of age, only smoking was associatedpressure. In elderly patients systolic blood pressure and
with arterial damage.
body mass index were significantly correlated with glo-
Repeating the multiple and the logistic regression
merulosclerosis. analyses using the categorization current smoker/non-
Logistic regression analysis for the presence or ab- smoker instead of ever-smoker/never-smoker did not
sence of arteriolar hyalinosis also showed an association change the findings. Neither total cholesterol nor triglyc-
between hyalinosis and systolic blood pressure (Table eride serum concentrations contributed significantly to
6). The same association was observed in subgroup anal- the calculated models.
yses in males, females and patients over and under fifty
years of age. In younger patients a trend toward arterio-
DISCUSSIONlar changes was evident for smoking (P  0.20).
The logistic regression analysis for the presence of One of the multiple deleterious health effects of ciga-
myointimal hyperplasia showed a significant correlation rette smoking is damage to the vascular system. Smoking
is an established risk factor for arteriosclerosis [15] in-of arterial damage with ever-smoking and a negative one
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cluding the renal arteries [16]. It also is associated with and both factors may hide any influence of smoking.
Again, smoking may have an indirect damaging effectarteriolar hyalinosis and thickening of small arteries in
the kidney and various other organs [11–13], as deter- on glomeruli via blood pressure. Therefore, our study
should not be taken as evidence against the damagingmined by autopsy studies in individuals without any
other vascular disease. Functional studies also point to effect of smoking on glomeruli and arterioles.
The negative association between glomerulosclerosisa renal vascular effect of nicotine. In healthy volunteers
smoking increases blood pressure, heart rate and reno- and age in our patients is somewhat unexpected. In indi-
viduals without kidney disease aging leads to progressivevascular resistance and decreases glomerular filtration
rate [17]. These effects are most likely caused by intra- glomerulosclerosis, usually causing complete sclerosis
of 10 to 30% of glomeruli by the age of eighty [26].renal vasoconstriction. Smokers and ex-smokers have
reduced renal plasma flow as compared to nonsmokers Our patients, however, all suffered from kidney disease,
mainly glomerulonephritis, and we also considered glo-[18]. In chronic smokers the effects of nicotine on blood
pressure and heart rate are preserved, but nicotine nei- meruli with segmental sclerosis to be affected. In addi-
tion, this negative association may have been caused byther decreases renal plasma flow nor glomerular filtration
rate [19]. Both observations in smokers point to a fixed our biopsy policy, which is to perform a biopsy in younger
patients with chronic disease and severely reduced renalnarrowing of intrarenal vessels in these individuals.
Several mechanisms may be operative in inducing re- function, but not in elderly patients.
Our study was unable to show a negative effect ofnal vasoconstriction and vascular damage. Nicotine in-
creases plasma levels of vasoconstrictors such as cate- smoking on renal function. This is in contrast to the
results of Orth and colleagues in patients with IgA ne-cholamines, arginine vasopressin and endothelin-1, and
thereby causes hypertension [17, 18, 20]. It induces a phropathy [10] and of Stengel et al in patients with
chronic glomerulonephritis [5], who demonstrated a det-thrombogenic state and perturbs arachidonic acid metab-
olism [21, 22]. Cigarette smoke damages endothelial rimental influence of nicotine on renal function. Our
patient group, contrary to the other studies, includedcells, and nicotine induces smooth muscle cell prolifera-
tion [23, 24]. In consideration of these facts the assump- patients with rapidly progressive glomerulonephritis and
other aggressive diseases such as proliferative lupus ne-tion that the negative effect of smoking on the course
of various kidney diseases [5–10] is caused by intrarenal phritis. In these patients who have the fastest decline
in renal function, the aggressive inflammatory processvascular damage is a legitimate one. Definite proof, how-
ever, would require the demonstration of vascular changes responsible for loss of renal function probably renders
any influence of smoking undetectable. This is in linein the kidneys of patients with preexisting disease and
their correlation with smoking habits of patients in a with the observation that the loss of renal function attrib-
utable to cigarette smoking seems to occur very slowlyprospective fashion. Such a study also would rely on
repeat renal biopsies. Clearly this is not feasible for ethi- [25].
In female patients we were unable to demonstrate acal reasons. Our study is the first to show an association
between vascular damage in renal biopsies and smoking negative effect of smoking on small renal arteries, which
is in accordance with two other studies [5, 10]. This raiseshabits of patients with kidney disease. Indeed, we dem-
onstrate a significant correlation between ever-smoking the question whether women are protected from the
negative effects of cigarette smoking on the kidney. In alland myointimal hyperplasia of small arteries. This associ-
ation was present in the entire patient group, in patients three studies, however, the relative frequency of female
patients was much smaller, and the proportion of femaleover fifty years of age and in men, but not in younger
patients or females. This is in accordance with other patients who smoke was considerably lower as compared
to males. Furthermore, female smokers smoked less thangroups, who also showed that smoking mainly affects
the kidney in men [5, 10] and older patients [5]. half as many pack-years as male smokers. Together with
a clear dose-effect of smoking shown in previous studiesThere was a trend toward the presence of arteriolar
hyalinosis in ever-smokers that, however, did not reach [5, 10], we believe that a demonstration of a detrimental
influence of smoking on renal function and morphologysignificance. The main factor predicting arteriolar hyali-
nosis was systolic blood pressure. As smoking causes requires much larger cohorts of female patients than
previously investigated.hypertension [25], cigarette smoking may well affect ar-
terioles via high blood pressure. Only a small minority of our patients took angiotensin-
converting enzyme (ACE) inhibitor treatment at theGlomerular sclerosis also did not seem to be affected
by smoking. The great majority of patients suffered from time of biopsy, and therefore we were unable to answer
the question whether such treatment abrogates vascularglomerulonephritis, and it is conceivable that in glomeru-
lonephritis glomerulosclerosis is mainly dependent on damage by tobacco abuse as suggested by Orth and col-
leagues [10]. Nevertheless, ACE inhibitors have beenthe inflammatory process in the glomeruli. In addition,
blood pressure was associated with glomerulosclerosis, shown to prevent myointimal hyperplasia of small ar-
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